Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas
article
OA: closed
CC0
⤵ 70 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (32)
- Apoptosis and Ki-67 expression in adenomyotic lesions and in the corresponding eutopic endometrium via openalex
- Aromatase expression in endometriosis. via openalex
- Danazol. A synthetic steroid with diverse biologic effects. via openalex
- Danazol inhibits steroidogenesis by the human ovary in vivo via openalex
- Danazol Suppresses the Production of Interleukin‐1β and Tumor Necrosis Factor by Human Monocytes via openalex
- Dating the Endometrial Biopsy via openalex
- Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis via openalex
- Direct effects of medroxyprogesterone acetate, danazol, and leuprolide acetate on endometrial stromal cell proliferation in vitro via openalex
- Estrogen and progesterone receptors in endometriotic tissue and endometrium: comparison according to localization and recurrence via openalex
- Estrogen and progesterone receptors in endometriotic tissue and endometrium: comparison according to localization and recurrence. via openalex
- Estrogen biosynthesis in human uterine adenomyosis via openalex
- Evidence for estrogen synthesis in adenomyotic tissues via openalex
- Expression of Aromatase Cytochrome P450 Protein and Messenger Ribonucleic Acid in Human Endometriotic and Adenomyotic Tissues but not in Normal Endometrium1 via openalex
- Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy via openalex
- Progesterone Induction of 17β-Hydroxysteroid Dehydrogenase Type 2 during the Secretory Phase Occurs in the Endometrium of Estrogen-Dependent Benign Diseases But Not in Normal Endometrium via openalex
- Stimulation of Aromatase P450 Promoter (II) Activity in Endometriosis and Its Inhibition in Endometrium Are Regulated by Competitive Binding of Steroidogenic Factor-1 and Chicken Ovalbumin Upstream Promoter Transcription Factor to the Same cis-Acting Element via openalex
- W2163168485 via openalex
- W2001831389 via openalex
- W1912234690 via openalex
- W1618997004 via openalex
- W2410375834 via openalex
- W185315057 via openalex
- W6650593333 via openalex
- W6654009425 via openalex
- W6656356435 via openalex
- W6668069468 via openalex
- W2014628274 via openalex
- W6684404551 via openalex
- W2066084415 via openalex
- W2069877703 via openalex
- W2009307286 via openalex
- W2126486896 via openalex
Cited by (50)
- Hormone receptor profile of ectopic and eutopic endometrium in adenomyosis: a systematic review 2025
- Evaluating the Impact of Long-Term GnRH Agonist Therapy on Pregnancy Outcomes in Endometriosis-Associated Implantation Failure and Pregnancy Loss 2024
- Hormonal Therapies before in vitro fertilization in women with endometriosis: The Minotaur's Labyrinth and the Ariadne's Thread 2024
- Hormonal Therapies before In-Vitro Fertilization in Women with Endometriosis 2024
- Medical Management of Ovarian Endometriomas 2023
- The role of the junctional zone in the management of adenomyosis with infertility 2023
- The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review 2023
- Androgen Signaling in Uterine Diseases: New Insights and New Targets 2022
- GnRH Agonists and Antagonists in Endometriosis and Adenomyosis Therapy 2022
- Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism 2022
- Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis 2022
- Hormonal Therapy in Endometriosis and Adenomyosis: Danazol, Aromatase Inhibitors 2022
- A Validated Model for Individualized Prediction of Live Birth in Patients With Adenomyosis Undergoing Frozen–Thawed Embryo Transfer 2022
- A Validated Model for Individualized Prediction of Live Birth in Patients With Adenomyosis Undergoing Frozen-Thawed Embryo Transfer 2021
- Impact of Gonadotropin-Releasing Hormone Agonist Pre-treatment on the Cumulative Live Birth Rate in Infertile Women With Adenomyosis Treated With IVF/ICSI: A Retrospective Cohort Study 2020
- Systematic review and meta‐analysis of adverse pregnancy outcomes after uterine adenomyosis 2019
- High-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone analogs (GnRHa) and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis: a case series with long-term follow up 2019
- Faculty Opinions recommendation of The impact of adenomyosis on women's fertility. 2019
- Co-morbidity of type 1 diabetes and endometriosis: bringing a new paradigm into focus 2019
- Benign Uterine Diseases 2019
- Treatment options and reproductive outcome for adenomyosis-associated infertility 2017
- Investigational Medical Therapies for Endometriosis: Current Data and Future Trends 2017
- Activin A Stimulates Aromatase via the ALK4-Smad Pathway in Endometriosis 2016
- Aromatase Inhibitors for Endometriosis-Associated Infertility; Do We Have Sufficient Evidence? 2016
- Current and Future Medical Treatment of Adenomyosis 2016
- Current Treatment for Adenomyosis 2015
- Treatment of pain associated with deep endometriosis: alternatives and evidence 2015
- Adenomyosis: What is New? 2015
- Adenomyosis: A Clinical Review of a Challenging Gynecologic Condition 2015
- Adénomyose et implantation : mise au point 2015
- The Endometrium in Adenomyosis 2015
- Human Adenomyosis Endometrium Stromal Cells Secreting More Nerve Growth Factor 2014
- Structural and molecular features of the endomyometrium in endometriosis and adenomyosis 2013
- Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis 2013
- Differential expression of steroidogenic enzymes according to endometriosis type 2013
- Assessing the efficacy of aspiration and ethanol injection in recurrent endometrioma before IVF cycle: A randomized clinical trial. 2013
- The Expression Status of G Protein-Coupled Receptor GPR30 Is Associated with the Clinical Characteristics of Endometriosis 2013
- Role of Inflammation and Aromatase Expression in the Eutopic Endometrium and its Relationship with the Development of Endometriosis 2012
- The Endometrium in Adenomyosis 2012
- Infertility and Adenomyosis 2011
- Are aromatase inhibitors effective in endometriosis treatment? 2011
- steve bAccumulation of nerve growth factor and its receptors in the uterus and dorsal root ganglia in a mouse model of adenomyosis 2011
- Adenomyosis: Review of the Literature 2011
- 异常在位子宫内膜是内异症的病因吗？-在位内膜在内异症发病中的作用 2011
- The effect of adenomyosis on in vitro fertilisation and intra-cytoplasmic sperm injection treatment outcome 2011
- Molecular profiling of human endometrium and endometriosis 2010
- Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy 2009
- Is aromatase expression in the endometrium the cause of endometriosis and related infertility? 2009
- Absence of aromatase protein and mRNA expression in endometriosis 2009
- Non-contraceptive health benefits of oral contraceptives 2008
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:12:55.732728+00:00
License: CC0
· commercial use OK